IRIS
VICENTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 362
SA - Sud America 104
NA - Nord America 51
EU - Europa 26
AF - Africa 14
OC - Oceania 1
Totale 558
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 129
CN - Cina 106
BR - Brasile 78
VN - Vietnam 70
HK - Hong Kong 30
US - Stati Uniti d'America 30
IT - Italia 15
MX - Messico 15
AR - Argentina 10
ID - Indonesia 6
EC - Ecuador 5
PY - Paraguay 5
PK - Pakistan 4
BD - Bangladesh 3
CL - Cile 3
RU - Federazione Russa 3
ZA - Sudafrica 3
AT - Austria 2
CO - Colombia 2
GE - Georgia 2
IN - India 2
NE - Niger 2
PL - Polonia 2
SA - Arabia Saudita 2
SN - Senegal 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BE - Belgio 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EG - Egitto 1
FR - Francia 1
GT - Guatemala 1
HN - Honduras 1
IE - Irlanda 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
LC - Santa Lucia 1
MA - Marocco 1
NI - Nicaragua 1
NL - Olanda 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
SD - Sudan 1
SY - Repubblica araba siriana 1
Totale 558
Salva come PNG Salva come JPEG
Città #
Beijing 44
Hong Kong 29
Ho Chi Minh City 28
Singapore 28
Ashburn 23
Mexico City 12
Hanoi 9
Biên Hòa 6
Salvador 6
New York 5
Ningbo 4
Quito 4
Rio de Janeiro 4
Rome 4
Thái Bình 4
Campinas 3
Haiphong 3
Milan 3
Ninh Bình 3
São Paulo 3
Asunción 2
Belo Horizonte 2
Bình Dương 2
Camaçari 2
Can Tho 2
Cape Town 2
Curitiba 2
Dakar 2
Denpasar 2
Itaquaquecetuba 2
Niamey 2
Riyadh 2
Taboão da Serra 2
Tashkent 2
Vienna 2
Abidjan 1
Alfenas 1
Apodaca 1
Baku 1
Balsas 1
Bambuí 1
Batam 1
Bilac 1
Boa Vista 1
Bogotá 1
Brasília 1
Brussels 1
Bắc Giang 1
Cairo 1
Cajamar 1
Cametá 1
Casablanca 1
Castries 1
Catanduva 1
Cosmópolis 1
Criciúma 1
Cruzeiro 1
Cuiabá 1
Da Nang 1
Dax 1
Del Viso 1
Dhaka 1
Djambala 1
Draper 1
Dublin 1
Encarnación 1
Goiânia 1
Guarulhos 1
Guayaquil 1
Gujranwala 1
Havana 1
Hortolândia 1
Hải Dương 1
Iguaba Grande 1
Ilhéus 1
Irecê 1
Islamabad 1
Itajaí 1
Itapecuru Mirim 1
Itumbiara 1
Jodhpur 1
Juiz de Fora 1
Khartoum 1
Kinshasa 1
Laferrere 1
Lagoa Salgada 1
Lima 1
Lobos 1
Londrina 1
Macaé 1
Malelane 1
Managua 1
Manaus 1
Manila 1
Marneuli 1
Mixco 1
Mogi das Cruzes 1
Molina 1
Mumbai 1
Najaf 1
Totale 320
Salva come PNG Salva come JPEG
Nome #
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 15
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 14
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 14
Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple 13
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 13
Distribution of different HBV DNA forms in plasma and peripheral blood mononuclear cells (PBMCs) of chronically infected patients with low or undetectable HBV plasma viremia 13
Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism 13
Natural variability in the HR-1 and HR-2 domains of HIV type 1 gp41 from different clades circulating in Italy 12
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 12
Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm) 11
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting 11
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 11
Evaluation of a commercial real-time PCR kit for the detection of the Q80K polymorphism in plasma from HCV genotype 1a infected patients 11
Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing 11
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 10
Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm 10
Hepatitis B virus vaccination in HIV-1-infected young adults: A tool to reduce the size of HIV-1 reservoirs? 10
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 10
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 10
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 9
Near Full-Length Sequence Analysis of HIV Type 1 BF Recombinants from Italy 9
Serendipitous identification of azine anticancer agents using a privileged scaffold morphing strategy 9
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 9
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 9
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 9
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 9
SARS-CoV2 infection in human testis and sperm: in vivo and in vitro studies 8
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 7
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 7
Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype 7
Two distinct hepatitis C virus genotype 1a clades have different geographical distribution and association with natural resistance to NS3 protease inhibitors 7
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection 7
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 7
Nucleoside Derivatives of 2,6-Diaminopurine Antivirals: Base-Modified Nucleosides with Broad-Spectrum Antimicrobial Properties 7
Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro 7
Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort 7
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 7
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 7
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 7
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 7
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 7
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic 6
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge 6
Rules-based HIV-1 genotypic resistance interpretation systems predict 8-week and 24-week virological antiretroviral treatment outcome and benefit from drug potency weighting 6
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication 6
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 6
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 6
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy’s outcome for HIV-1 6
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 6
Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania 6
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 6
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 6
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants 6
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 6
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3 6
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors 6
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 6
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 6
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 6
HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France) 6
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 6
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination 6
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 6
SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19 5
Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021 5
Impact of remote vs. local sampling on sensitivity of genotypic antiretroviral resistance testing 5
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy 5
Use of peripheral blood DNA for genotypic antiretroviral resistance testing in drug-naïve HIV-infected subjects 5
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 5
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 5
Detection of residual human immunodeficiency virus type 1 reverse transcriptase K103N minority species in plasma RNA and peripheral blood mononuclear cell DNA following discontinuation of non-nucleoside therapy 5
Low-cost simultaneous detection of CCR5-delta32 and HLA-B*5701 alleles in human immunodeficiency virus type 1 infected patients by selective multiplex endpoint PCR 5
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity 5
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 5
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 5
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 5
SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy 5
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 5
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 5
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 5
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 5
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 5
A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations 5
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 4
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database 4
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 4
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 4
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 3
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA 3
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration 3
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies 2
Totale 652
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026652 83 15 216 139 139 60 0 0 0 0 0 0
Totale 652